The receptors and neurotransmitter pathways that may participate in the inhibitory action of 5-hydroxytryptamine (5HT) on prolactin release during late pregnancy and lactation in rats were studied. Administration of the 5HT synthesis inhibitor, p\ x =r eq-\ chlorophenylalanine, to late pregnant rats induced a significant increase in serum prolactin concentrations at 17:00 h on day 19 of pregnancy that was partially blocked by injections of the 5HT precursor, 5-hydroxytryptophan, or the 5HT agonists, 8-hydroxy\x=req-\ 2-(di-n-propylamino)-tetralin hydrobromide (S1a), 1-(2,5-dimethoxy-4-iodophenyl)-2\x=req-\ aminopropane (S2) and N-(3-chlorophenyl)imidodicarbonimide diamide HC1 (S3), but not by RU 24969 (S1b) or 1-meta-(chlorophenyl)-piperazine-2-HCl (S1a-2c 
Introduction 5-Hydroxytryptamine (5HT or serotonin) has been implicated in the regulation of prolactin release in various physiological or experimental situations as a stimulatory agent (Wilson, 1979; Kordon et ah, 1994) . The general consensus is that S2 receptors mediate this action (Pan and Gala, 1988; Di Renzo et ah, 1989; Jörgensen et ah, 1993) , although activation of SI and S3 receptors also stimulates prolactin release in certain situations (Jörgensen et ah, 1993; Kellar et ah, 1992; Pan and Yang, 1996) . Dual regulation of prolactin release by 5HT in pregnant and lactating rats (Jahn and Deis, 1987 Deis, ,1988 Deis, ,1994 has been demonstrated using the 5HT synthesis inhibitor, p-chlorophenylalanine (pCPA) Molliver, 1990) , such as pchloroamphetamine (pCA; Meek, 1978; Sanders-Busch and Steranka, 1978) and fenfluramine (FEN; Clineschmidt et ah, 1978 ; Kleven and Seiden, 1989) . Serotoninergic pathways participate in the stimulation of prolactin release in prooestrus, during the first 9 days of pregnancy and in suckling-lactating rats (Jahn and Deis, 1987 Deis, , 1988 Deis, , 1994 . However, there seems also to be an inhibitory pathway, operative mainly at the end of pregnancy and in lactating rats that have been separated from their litters, that operates alongside the well known stimulatory pathway, at least in lactating rats (Jahn and Deis, 1994; Kordon et ah, 1973/74 Deis, 1994 ).
The hypothalamus is the main site of action of 5HT in the control of prolactin release (Wilson, 1979) . Manipulation of serotoninergic pathways modifies dopaminergic and noradrenergic transmission (Burri et ah, 1987; Nissbrandt et ah, 1992; Blier et ah, 1990; Done and Sharp, 1992; Blandina et ah, 1991) and these actions have been correlated with the effects on LH secretion (Burri et ah, 1987 is inhibitory (Jahn and Deis, 1987,1988 (Fig. 2) . In contrast to the effect of pCPA (Fig. 1) , there was no effect of the neurotoxins on day 19 of pregnancy at 17:00 h. On day 21 at 18.00 h, the neurotoxins also significantly reduced the prepartum surge of prolactin, while two doses of 200 mg pCPA kg"1 given at 12:00 h on days 18 and 20, did not alter prolactin concentrations (Fig. 2) before delivery potentiates this effect, increasing further the concentrations of prolactin (Vermouth and Deis, 1974; Jahn and Deis, 1987) . The serotoninergic, adrenergic and opioid systems have been studied using diverse pharmacological approaches (Jahn and Deis, 1987 ,1988 ,1991 ,1994 Soaje and Deis, 1994, 1997) to attempt to elucidate the neurotransmitters and pathways involved in the regulatory action of progesterone. 5-Hydroxytryptamine and opioids, which in most circumstances stimulate prolactin release, were found to be inhibitory at the end of pregnancy, while adrenergic agents, which do not seem to have an important participation in physiological stimulation of prolactin release (by pro-oestrus, lactation or stress), were clearly stimulatory. However, the inhibitory action of 5HT does not seem to be related or to mediate the inhibitory action of progesterone, since the effect of pCPA is similar in intact and in ovariectomized pregnant rats and, conversely, no 5HT antagonists so far tested prevent the increase in prolactin induced by the progesterone decrease (Jahn and Deis, 1987 Deis, , 1988 . Thus, the neural pathways and neurotransmitters implicated in the regulation of prolactin secretion at late gestation in rats seem to be markedly different from those of other reproductive or physiological situations.
In the present study, the mechanisms and receptors implicated in the paradoxical inhibitory action of 5HT in late pregnancy and in lactating rats were investigated. Present and previous (Jahn and Deis, 1987 Deis, , 1988 Deis, , 1994 
